Arrayit Extends Worldwide Licensing of Its Patented High-Throughput Genotyping Platform to Belmedtechnika
Integrated Media Holdings Inc has announced that its wholly owned subsidiary, TeleChem International Inc, doing business as Arrayit Company, has entered into a licensing agreement with Belmedtechnika for the supply and license rights of the state-of-the-art patented microarray platform and associated reagents.
The Arrayit platform will empower Belmedtechnika to deploy Arrayit’s massively parallel high-throughput genotyping platform to screen and test a large number of patient samples quickly, affordably, and accurately.
Ms Rene Schena, CEO of Arrayit, stated, "Arrayit is pleased to license our patented genotyping platform to Belmedtechnika. We believe that the capacity to easily and affordably screen a large number of patient samples for disease-carrying traits will be transformative in health care."
Pursuant to a contract signed between the parties on June 30th, 2008, and effective with its funding on January 9, 2009, this licensing agreement permits Belmedtechnika to utilize the Arrayit’s sophisticated multi-patient genotyping platform to examine the DNA of many patient samples at once. The agreement also gives Belmedtechnika the right to use Arrayit’s patented contact printing technology for diagnostic applications.
